Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$35.25
+2.7%
$35.25
$28.58
$38.19
$1.80B1.48813,590 shs151,128 shs
Moderna, Inc. stock logo
MRNA
Moderna
$107.67
+3.1%
$100.94
$62.55
$142.79
$41.22B1.624.10 million shs868,908 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
+0.91%+2.05%-1.07%+1.66%+3.28%
Moderna, Inc. stock logo
MRNA
Moderna
+3.01%+0.58%-0.92%+2.49%-25.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
3.6718 of 5 stars
2.02.02.51.72.01.72.5
Moderna, Inc. stock logo
MRNA
Moderna
3.955 of 5 stars
3.12.00.04.61.93.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
2.08
Hold$35.641.10% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.24
Hold$126.4917.48% Upside

Current Analyst Ratings

Latest CAKE and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight$44.00
4/11/2024
Moderna, Inc. stock logo
MRNA
Moderna
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/10/2024
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$40.00
4/9/2024
Moderna, Inc. stock logo
MRNA
Moderna
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$125.00
4/1/2024
Moderna, Inc. stock logo
MRNA
Moderna
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/28/2024
Moderna, Inc. stock logo
MRNA
Moderna
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$125.00
3/28/2024
Moderna, Inc. stock logo
MRNA
Moderna
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
2/26/2024
Moderna, Inc. stock logo
MRNA
Moderna
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Reduce$75.00 ➝ $86.00
2/23/2024
Moderna, Inc. stock logo
MRNA
Moderna
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$125.00
2/23/2024
Moderna, Inc. stock logo
MRNA
Moderna
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$82.00 ➝ $91.00
2/22/2024
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$33.00 ➝ $37.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$3.44B0.52$4.60 per share7.67$6.26 per share5.63
Moderna, Inc. stock logo
MRNA
Moderna
$6.85B6.02N/AN/A$36.33 per share2.96

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$101.35M$2.0617.1110.191.082.95%41.66%4.74%5/8/2024 (Confirmed)
Moderna, Inc. stock logo
MRNA
Moderna
-$4.71B-$12.41N/AN/AN/A-68.84%-10.23%-7.70%5/2/2024 (Confirmed)

Latest CAKE and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$0.62N/A-$0.62N/AN/AN/A  
5/2/2024N/A
Moderna, Inc. stock logo
MRNA
Moderna
-$3.36N/A+$3.36N/AN/AN/A  
2/22/2024Q4 2023
Moderna, Inc. stock logo
MRNA
Moderna
-$0.78$0.55+$1.33$0.55$2.53 billion$2.80 billion    
2/21/2024Q4 23
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$0.73$0.80+$0.07$1.34$876.17 million$877.00 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$1.083.06%+44.22%52.43%N/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest CAKE and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Quarterly$0.273.06%3/5/20243/6/20243/19/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
1.48
0.46
0.37
Moderna, Inc. stock logo
MRNA
Moderna
0.04
3.42
3.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
94.48%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
8.70%
Moderna, Inc. stock logo
MRNA
Moderna
15.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
47,90051.04 million46.60 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
5,600382.88 million324.68 millionOptionable

CAKE and MRNA Headlines

SourceHeadline
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patentsModerna, Pfizer/BioNTech set for UK court clash over COVID jab patents
medicalxpress.com - April 23 at 11:21 AM
Moderna gets grant for vaccine composition for varicella zoster virusModerna gets grant for vaccine composition for varicella zoster virus
pharmaceutical-technology.com - April 23 at 11:21 AM
This may hurt: English High Court set for Moderna and Pfizer/BioNTech Covid battle starting todayThis may hurt: English High Court set for Moderna and Pfizer/BioNTech Covid battle starting today
msn.com - April 23 at 11:21 AM
Pfizer vs Moderna battle over COVID vaccine patents begins in UKPfizer vs Moderna battle over COVID vaccine patents begins in UK
reuters.com - April 23 at 7:21 AM
Moderna halts planned vaccine plant in KenyaModerna halts planned vaccine plant in Kenya
independent.co.ug - April 22 at 6:53 PM
Cwm LLC Has $11.77 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Cwm LLC Has $11.77 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)
marketbeat.com - April 22 at 8:41 AM
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination CampaignModerna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
accesswire.com - April 22 at 7:00 AM
Covid vaccine makers to clash in London over mRNA patent disputeCovid vaccine makers to clash in London over mRNA patent dispute
ft.com - April 22 at 12:45 AM
Noubar Afeyan Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockNoubar Afeyan Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
insidertrades.com - April 21 at 4:24 AM
Moderna stock traded in the red for the eighth straight dayModerna stock traded in the red for the eighth straight day
seekingalpha.com - April 20 at 7:07 PM
Moderna, Inc. (NASDAQ:MRNA) is APEIRON CAPITAL Ltds 7th Largest PositionModerna, Inc. (NASDAQ:MRNA) is APEIRON CAPITAL Ltd's 7th Largest Position
marketbeat.com - April 20 at 4:23 PM
Fact Check: mRNA Jabs Have Allegedly Caused a 14,000% Increase in Turbo Cancer. Heres What We FoundFact Check: mRNA Jabs Have Allegedly Caused a '14,000% Increase in Turbo Cancer.' Here's What We Found
news.yahoo.com - April 20 at 2:07 PM
Moderna, Inc. (NASDAQ:MRNA) Director Sells $1,550,700.00 in StockModerna, Inc. (NASDAQ:MRNA) Director Sells $1,550,700.00 in Stock
insidertrades.com - April 20 at 7:12 AM
CDC Said mRNA Jabs Have Caused a 14,000% Increase in Turbo Cancer?CDC Said mRNA Jabs Have Caused a '14,000% Increase in Turbo Cancer'?
msn.com - April 20 at 12:46 AM
Moderna stock on track for the eighth consecutive day of lossesModerna stock on track for the eighth consecutive day of losses
msn.com - April 19 at 7:42 PM
The next phase for mRNA: Looking beyond COVID-19The next phase for mRNA: Looking beyond COVID-19
pharmaceutical-technology.com - April 19 at 8:04 AM
Stephen Hoge Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) StockStephen Hoge Sells 15,000 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
americanbankingnews.com - April 19 at 4:34 AM
Chinas drugmakers cant sell mRNA shots but havent quit yetChina's drugmakers can't sell mRNA shots but haven't quit yet
yahoo.com - April 19 at 1:42 AM
Focus: Chinas drugmakers cant sell mRNA shots but havent quit yetFocus: China's drugmakers can't sell mRNA shots but haven't quit yet
reuters.com - April 19 at 1:42 AM
FOCUS-Chinas drugmakers cant sell mRNA shots but havent quit yetFOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
finance.yahoo.com - April 19 at 1:42 AM
Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 15,000 SharesModerna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 15,000 Shares
insidertrades.com - April 18 at 6:16 AM
Moderna, Inc. (MRNA)Moderna, Inc. (MRNA)
finance.yahoo.com - April 17 at 11:03 PM
Moderna Options Trading: A Deep Dive into Market SentimentModerna Options Trading: A Deep Dive into Market Sentiment
benzinga.com - April 17 at 1:02 PM
Africa CDC blasts Moderna after it halts plans to build vaccine plant in KenyaAfrica CDC blasts Moderna after it halts plans to build vaccine plant in Kenya
fiercepharma.com - April 17 at 1:02 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cheesecake Factory logo

Cheesecake Factory

NASDAQ:CAKE
The Cheesecake Factory Incorporated operates and licenses restaurants in the United States and Canada. The company operates bakeries that produce cheesecakes and other baked products for its restaurants, international licensees, third-party bakery customers, external foodservice operators, retailers, and distributors. It operates restaurants under the brands comprising The Cheesecake Factory, North Italia, Flower Child, Fox Restaurant Concepts. The Cheesecake Factory Incorporated was founded in 1972 and is headquartered in Calabasas, California.
Moderna logo

Moderna

NASDAQ:MRNA
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.